Business Medical Dialogues
    • facebook
    • twitter
    Sign in Signup
    • facebook
    • twitter
    Sign in Signup
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    Sign InRegister
    Business Medical Dialogues
    Sign inRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Delhi High Court...

    Delhi High Court directs Centre to provide partial list of OTC drugs to doctors, pharmacists

    Medical Dialogues BureauBy Medical Dialogues BureauPublished On 2019-07-05T09:30:30+05:30  |  Updated On 2021-08-16T13:53:08+05:30

    "As things stand today, it is not that difficult to provide a list of OTC drugs," the court said, directing that a "partial list" be provided to doctors before the next date of hearing on September 12.


    New Delhi: The Delhi High Court Wednesday directed the Centre to provide a "partial list" of over the counter (OTC) drugs to doctors and pharmacists by September 12. A bench of Chief Justice D N Patel and Justice C Hari Shankar issued the direction on a PIL initiated by the court on its own after receiving a letter from a doctor for the formulation of a law relating to OTC drugs and preparation of a list of such medication.


    "You (Centre) already know which are the scheduled drugs. So, collate the remaining medicines into a list and provide it to them," the court told the central government standing counsel Ajay Digpaul, representing the health ministry.


    Digpaul told the court that a sub-committee constituted by the 52nd Drugs Consultative Committee (DCC) has already examined the issue raised in the PIL and has given a report on several aspects regarding OTC drugs including its definition, basic characteristics, manufacturing, labelling, distribution, sale and pricing.


    He said that the sub-committee report was being examined by another sub-committee which shall give its final report in three months to the DCC which will forward it to the Drugs Technical Advisory Board (DTAB) for further consideration.


    However, the bench was not impressed and said that going by the status report shown to it, the government appears to "have not understood what they (doctors) are asking for".


    "As things stand today, it is not that difficult to provide a list of OTC drugs," the court said, directing that a "partial list" be provided to doctors before the next date of hearing on September 12.


    The PIL was initiated by the court after receiving a letter from Dr K K Aggarwal, a Padma Shree awardee and the National President of Heart Care Foundation of India(HCFI), seeking formulation of law regarding OTC drugs and preparation of a list of such medicines in India.


    Aggarwal, who has been appointed as amicus curiae to assist the court in the matter, has contended that the list of OTC drugs would help to advance consumer health because it would allow people to treat or manage many health conditions conveniently and successfully.


    Also Read: Johnson n Johnson Slapped Rs 213 crore over lawsuit of Benadryl and other OTC drugs

    (DCC) CDSCO Chief Justice D N Patel Delhi high court doctors Dr K K Aggarwal drugs Drugs Consultative Committee Drugs Technical Advisory Board DTAB HCFI Heart Care Foundation of India Justice C Hari Shankar list of OTC drugs OTC drugs 
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

      Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

      Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

      Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society...

      Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

      Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

      Pharmaceuticals safe in PET packaging: High-level committee

      Pharmaceuticals safe in PET packaging: High-level committee

      Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

      Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

      NPPA fixes prices of 29 formulations under DPCO, check out details

      NPPA fixes prices of 29 formulations under DPCO, check out details

      Top priority on Delivery of Medicines through Speed Post: Minister

      Top priority on Delivery of Medicines through Speed Post: Minister

      View All

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 29 March 2022 11:15 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
      verify here.

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
      X
      X